This post is from a suggested group
India API: Accelerating Pharmaceutical Self-Reliance and Global Leadership
India’s Active Pharmaceutical Ingredients (API) ecosystem has undergone a remarkable transformation, evolving from a supporting segment within the pharmaceutical supply chain to a strategic pillar of national healthcare and industrial resilience. Known globally as the “Pharmacy of the World,” India’s focus is now shifting toward strengthening its API manufacturing capacity to reduce dependence on foreign sources and establish itself as a leading global API hub. This shift is driven by innovation, policy support, and a rising demand for quality-assured raw materials.
API production in India has long been recognized for its cost-effective processes and skilled scientific workforce. However, the country has historically relied on imports—particularly from China—for certain key APIs and intermediates. Over the last few years, India’s commitment to achieving pharmaceutical self-reliance has intensified. With increasing emphasis on indigenous production, modernizing manufacturing technologies, and supporting domestic industries, the API segment is…